Aprea Therapeutics
SwedenWho owns Aprea Therapeutics?
Aprea Therapeutics is a Swedish Biotech company, currently owned by Karolinska Development since 2003.
Hand-verified · updated 2026-06-30
Open JSON · CC-BYKey facts
- ·Held by Karolinska Development since 2003 (23Y hold).
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
3 ownership periods · co-invest detected
Rosetta Capital took Aprea Therapeutics public via IPO in 2019 after 6 years.
HealthCap took Aprea Therapeutics public via IPO in 2019 after 3 years.
More from Karolinska Development
Other portfolio companies in the same fund.
Denmark
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Aprea Therapeutics?
Aprea Therapeutics is currently owned by Karolinska Development, through Karolinska Development, since 2003.
When did Karolinska Development acquire Aprea Therapeutics?
Karolinska Development acquired Aprea Therapeutics in 2003.
Who has owned Aprea Therapeutics over time?
Aprea Therapeutics has been through 3 private-equity ownership periods: Karolinska Development · via Karolinska Development · since 2003; Rosetta Capital · via Rosetta Capital IV · 2013–2019 · (IPO); HealthCap · via HealthCap VII · 2016–2019 · (IPO).